Application of regulation of reactive oxygen species and lipid peroxidation to disease treatment

Mototada Shichiri1, Hiroshi Suzuki2, Yuji Isegawa3

  • 1Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-8-31 Midorigaoka, Ikeda, Osaka 563-8577, Japan.

Insights

This study explores using antioxidants, reactive oxygen species (ROS), and lipid mediators for disease treatment. It highlights the importance of timing for antioxidant therapy and novel strategies involving cell death induction and mediator modulation.

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Oxidative Stress Research

Background:

  • Reactive oxygen species (ROS) and free radicals are implicated in numerous diseases.
  • While antioxidants are known, their therapeutic application remains limited.
  • Understanding ROS and lipid oxidation is crucial for developing new treatments.

Purpose of the Study:

  • To discuss four key concepts for disease treatment by regulating ROS, free radicals, and lipid oxidation.
  • To explore the therapeutic potential of antioxidants, ferroptosis induction, and lipid mediator modulation.
  • To propose novel strategies for disease management based on current research.

Main Methods:

  • Review of existing research on antioxidants and ROS.
  • Discussion of methods for inducing ferroptosis (iron-dependent cell death).
  • Analysis of drugs inhibiting lipid mediator synthesis (e.g., cyclooxygenase, leukotriene, lipoxygenase inhibitors).
  • Exploration of inducing beneficial lipid mediators (pro-resolving mediators) for disease control.

Main Results:

  • Antioxidant therapy effectiveness is highly dependent on the timing of intervention.
  • Ferroptosis induction presents a viable therapeutic strategy.
  • Inhibiting inflammatory lipid mediator synthesis offers treatment possibilities.
  • Inducing pro-resolving mediators shows promise for treating inflammatory diseases.

Conclusions:

  • Strategic regulation of ROS, free radicals, and lipid oxidation offers diverse therapeutic avenues.
  • Timing and specific mechanisms (e.g., ferroptosis, mediator modulation) are critical for successful treatment.
  • Further research into compounds that modulate lipid mediators could lead to new disease treatments.

Related Concept Videos

Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
13.8K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
3.3K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
324
Redox Reactions01:27

Redox Reactions

Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
67